COVID-19 vaccines

Pfizer on track for US vaccine boosters, Moderna lagging, says Fauci

Reuters

This is AI generated summarization, which may have errors. For context, always refer to the full article.

Pfizer on track for US vaccine boosters, Moderna lagging, says Fauci

VACCINES. Vials with Pfizer-BioNTech and Moderna COVID-19 vaccine labels are seen in this illustration picture taken March 19, 2021.

File photo by Dado Ruvic/Reuters

How – or even whether – to administer boosters has emerged as a thorny issue as COVID-19 continues to kill unvaccinated people around the world

Top US infectious disease expert Dr. Anthony Fauci said on Sunday, September 5, that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made by Pfizer, although Moderna booster could take a little longer.

Asked on CBS’ “Face the Nation,” about President Joe Biden’s goal to give booster shots starting September 20, Fauci said that “in some respects” that remained the plan.

But he said that while Pfizer-BioNTech has submitted the necessary data on booster shots to the Food and Drug Administration (FDA), Moderna has yet to complete the process. Fauci said he hopes to give both vaccines when boosters doses roll out, but if Moderna does not complete the process before September 20, then Moderna boosters will be given later.

Moderna and the FDA did not immediately return emails seeking comment. In a statement released Wednesday, September 1, Moderna said it had “initiated its submission” of booster data to the FDA.

How – or even whether – to administer boosters has emerged as a thorny issue as COVID-19 continues to kill unvaccinated people around the world.

Pfizer on track for US vaccine boosters, Moderna lagging, says Fauci

Last month the Biden administration announced it would start offering boosters to Americans by September 20, usurping the process by which the FDA and the US Centers for Disease Control and Prevention usually decide on such issues, current and former FDA scientists and CDC advisory panel members have told Reuters.

Scientists are still debating how much additional immunity boosters provide and whether all Americans should get another shot, rather than just those at high risk of severe illness.

Must Read

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

Speaking Sunday, Fauci emphasized that both boosters were assumed to be safe, but that the FDA and other officials would study the data to make sure.

“When you’re dealing with allowing the American public to receive an intervention, you want to make sure you’re absolutely certain,” he said. – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!